Novo Nordisk
NVO
553 hedge funds and large institutions have $8.16B invested in Novo Nordisk in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 156 increasing their positions, 206 reducing their positions, and 53 closing their positions.
217% more call options, than puts
Call options by funds: $51.7M | Put options by funds: $16.3M
8% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 53
0% more funds holding
Funds holding: 552 → 553 (+1)
0.12% more ownership
Funds ownership: 16.76% → 16.88% (+0.12%)
8% less capital invested
Capital invested by funds: $8.82B → $8.16B (-$665M)
24% less repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 206
26% less funds holding in top 10
Funds holding in top 10: 19 → 14 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$79.2M |
| 2 |
Renaissance Technologies
New York
|
+$71.4M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$69.5M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$34.5M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$22.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$61.9M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$57.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$17.6M |
| 5 |
RBCM
Raub Brock Capital Management
Larkspur,
California
|
-$17.5M |
NVO Hedge Fund Activity: Q1 2018 in Review
553 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2018, worth a combined $8.16B — down 7.5% from $8.82B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new NVO positions and 53 closed out — a net gain of 4 holders — while 156 added to existing stakes and 206 trimmed.
The largest buyer was Eaton Vance Management, adding an estimated $79.2M. The largest seller was Folketrygdfondet, cutting an estimated $61.9M.
- 553 institutional investors held Novo Nordisk (NVO) as of Q1 2018, up from 552 in Q4 2017.
- Funds reported $8.16B of Novo Nordisk stock for Q1 2018, down 7.5% quarter-over-quarter.
- 57 funds opened new Novo Nordisk positions in Q1 2018 and 53 closed out, a net change of +4 holders.
- The largest Novo Nordisk buyer in Q1 2018 was Eaton Vance Management, an estimated $79.2M added.
- The largest Novo Nordisk seller in Q1 2018 was Folketrygdfondet, an estimated $61.9M sold.
Based on aggregated 13F filings for Q1 2018.